Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …

Since its initial reports in the 19th century, neuromyelitis optica (NMO) had been thought to
involve only the optic nerves and spinal cord. However, the discovery of highly specific anti–…

Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS demyelination…

A subset of patients has long-lasting symptoms after mild to moderate Coronavirus disease
2019 (COVID-19). In a prospective observational cohort study, we analyze clinical and …

Background The diagnostic and pathophysiological relevance of antibodies to aquaporin-4 (AQP4-Ab)
in patients with neuromyelitis optica spectrum disorders (NMOSD) has been …

Background A subset of patients with neuromyelitis optica spectrum disorders (NMOSD)
has been shown to be seropositive for myelin oligodendrocyte glycoprotein antibodies (MOG-…

Neuromyelitis optica (NMO, Devic’s syndrome), long considered a clinical variant of multiple
sclerosis, is now regarded as a distinct disease entity. Major progress has been made in the …

INTRODUCTION The clinical manifestations of COVID-19 vary from asymptomatic infection
to respiratory failure. Severe disease courses are primarily associated with advanced age, …

Background No approved therapies exist for neuromyelitis optica spectrum disorder (NMOSD),
a rare, relapsing, autoimmune, inflammatory disease of the CNS that causes blindness …

Background Alzheimer disease (AD) is the most common form of dementia but the identification
of reliable, early and non-invasive biomarkers remains a major challenge. We present a …